Skip to content

Blackcrane Capital, LLC

Follow

13F filer, CIK 1720745, BELLEVUE, WA

Blackcrane Capital, LLC reported $88,401,000 across 9 holdings for the quarter ended 2020-06-30, in a 13F-HR filed 2020-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001720745-20-000004

Period
2020-06-30
Reported value
$88.4M
Holdings
9
Top 10 weight
100%
New
2
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RCELnew+921,663$28.1M
ONCOCYTE CORPnew+2,982,557$5.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AVITA MEDICAL LTDexited-5,166,338-$32M
WIXreduced-107,295-$27.5M
MSFTreduced-67,922-$13.8M
AXONICS INCreduced-321,980-$11.3M
BIOHAVEN PHARMACEUTICAL HOL…reduced-145,003-$10.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2020

Share positions as resolved from 13F-HR 0001720745-20-000004, largest first. % of portfolio is the value over $88,401,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RCELAVITA MEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 921,663 shares 921,663$28.1M31.84%newTimeline
WIXWIX COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 62,379 shares 62,379$16M18.08%-107,295Timeline
AXONICS INCAXONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 428,359 shares 428,359$15M17.01%-321,980
BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDINQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 122,865 shares 122,865$8.98M10.16%-145,003
NICENICE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 43,657 shares 43,657$8.26M9.35%-23,194Timeline
ONCOCYTE CORPONCOCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 2,982,557 shares 2,982,557$5.7M6.44%new
PROFPROFOUND MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 175,301 shares 175,301$2.97M3.36%-47,246Timeline
MSFTMICROSOFT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 14,039 shares 14,039$2.86M3.23%-67,922Timeline
TAKTAKEDA PHARMACEUTICAL CO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q3: restricted; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 25,723 shares 25,723$461K0.52%-109,734Timeline

Sold out in Q2 2020

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AVITA MEDICAL LTDAVITA MEDICAL LTD5,166,338$32Mshares
VVISA INC33,024$5.32Mshares

How Q2 2020 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001720745-20-000004 base2020-08-14acceptance time not in the bulk data set